文献速递消化内镜消化道肿瘤与早癌

线缆传输磁控胶囊内镜系统检查上消化道疾病有效性与安全性的前瞻性多中心自身对照临床试验(附视频)

Prospective, multicenter, self-controlled clinical trial on the effectiveness and safety of a cable-transmission magnetically controlled capsule endoscopy system for the examination of upper GI diseases (with video).
PubMed 文献 · Gastrointest Endosc · 2024-08-05

这项前瞻性多中心自身对照试验在2022年10月至2023年7月纳入中国3家医院180例18至75岁上消化道疾病患者,比较线缆传输磁控胶囊内镜(CT-MCCE)与常规胃镜。CT-MCCE检测食管、胃、十二指肠球部局灶性病变的敏感度、特异度、阳性预测值、阴性预测值和准确率均较高,上消化道清洁度和黏膜可视性与胃镜无显著差异,不适感发生率低于胃镜(P < .001),未观察到不良事件。

要点

  • CT-MCCE检测食管病变敏感度97.22%、特异度100%、准确率98.89%。
  • CT-MCCE检测全胃局灶性病变敏感度96.81%、特异度98.84%、准确率97.78%。
  • CT-MCCE检测十二指肠球部病变敏感度、特异度、准确率均为100%,不适感低于胃镜(P < .001)。

核心结论

  • CT-MCCE在上消化道检查和病变检测方面的诊断性能与常规胃镜相当,且耐受性更好,未观察到不良事件。

研究设计与样本

  • 前瞻性、多中心、自身对照临床试验,2022年10月至2023年7月在中国3家医院纳入180例18至75岁上消化道疾病患者,比较CT-MCCE与常规胃镜。

主要发现

  • CT-MCCE检测食管病变的敏感度97.22%、特异度100%、阳性预测值100%、阴性预测值98.18%、准确率98.89%。
  • CT-MCCE检测全胃局灶性病变的敏感度96.81%、特异度98.84%、阳性预测值98.91%、阴性预测值96.59%、准确率97.78%。
  • CT-MCCE检测十二指肠球部病变的敏感度100%、特异度100%、阳性预测值100%、阴性预测值100%、准确率100%。
  • CT-MCCE与常规胃镜在上消化道清洁度和上消化道黏膜可视性方面无显著差异。
  • CT-MCCE的不适感发生率低于常规胃镜(P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Many GI disorders and precancerous conditions often present asymptomatically, leading to delayed patient diagnoses and treatment interventions. In this study, we developed a novel cable-transmission magnetically controlled capsule endoscopy (CT-MCCE) system for detecting GI diseases and assessed its safety and feasibility through clinical trials. METHODS: This prospective, multicenter trial compared CT-MCCE with conventional gastroscopy in patients aged 18 to 75 years with upper GI tract diseases between October 2022 and July 2023. The primary endpoints were the evaluation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in the detection of focal lesions within the esophagus, stomach, and duodenal bulb using CT-MCCE. RESULTS: One hundred eighty individuals (mean age, 43.1 years; 52.22% women) were recruited from 3 hospitals in China. CT-MCCE detected lesions in the esophagus with a sensitivity of 97.22%, specificity of 100%, PPV of 100%, NPV of 98.18%, and accuracy of 98.89%; detected gastric focal lesions in the entire stomach with a sensitivity of 96.81%, specificity of 98.84%, PPV of 98.91%, NPV of 96.59%, and accuracy of 97.78%; and detected lesions in the duodenal bulb with a sensitivity of 100%, specificity of 100%, PPV of 100%, NPV of 100%, and accuracy of 100%. There were no significant differences between CT-MCCE and EGD regarding the cleanliness of the upper GI tract and visibility of the upper GI mucosa. However, CT-MCCE was associated with a lower incidence of discomfort than EGD (P < .001). CONCLUSIONS: The diagnostic performance of CT-MCCE is comparable with that of EGD in the completion of upper GI tract examinations and lesion detection. Furthermore, the improved tolerance of CT-MCCE in detecting upper GI diseases was noted without any observed adverse events. (Clinical trial registration number: ChiCTR2200063630.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Tian Y, Du S, Liu H, et al. Prospective, multicenter, self-controlled clinical trial on the effectiveness and safety of a cable-transmission magnetically controlled capsule endoscopy system for the examination of upper GI diseases (with video). Gastrointest Endosc. 2024. PMID: 39111392. doi:10.1016/j.gie.2024.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。